Using physiological parameters to predict outcomes in cirrhotic patients with gastrointestinal bleeding

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate whether physiological indicators, such as the Shock Index and its variations, can accurately predict the prognosis of patients with liver cirrhosis experiencing gastrointestinal bleeding. By analyzing these indicators, the study seeks to enhance the management of emergency and critical care for this patient population. The research focuses on the application of established physiological measures to improve treatment decision-making in critical situations. The ultimate goal is to develop a reliable prognostic tool that can assist healthcare providers in delivering timely and effective care.

Why it matters

Who can join: the full rules

Inclusion Criteria: cirrhosis with gastrointestinal bleeding -

Exclusion Criteria: no complete medical record and trauma patient

\-

Where it's running

• St. Martin De Porres Hospital
  Tainan, Taiwan Recruiting

Study contacts

• Study coordinator: Chia-Hsi Chen, Physician
• Email: urologist3509@gmail.com
• Phone: 886-5-2756000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using spleen size to help detect gastroesophageal varices in compensated cirrhosis

  This study tests whether ultrasound measurements of spleen size can help identify esophageal varices in adults with compensated cirrhosis, compared with the standard endoscopy test.

  Recruiting Fifth Affiliated Hospital, Sun Yat-Sen University · Zhuhai, Guangdong · NCT07920744

• Endovascular treatment outcomes after portal hypertension–related GI bleeding in cirrhosis

  This study tests how well endovascular procedures for portal hypertension–related GI bleeding work in adults with cirrhosis, and what factors predict outcomes.

  Recruiting University Medical Center Ho Chi Minh City (UMC) · Ho Chi Minh City · NCT07918378

• Laparoscopic liver and spleen removal for small liver cancer in people with cirrhosis and enlarged spleen

  This study tests whether removing part of the liver and the spleen during one operation helps people with small liver cancers and hypersplenism by improving liver function and immune balance.

  Recruiting Northern Jiangsu People's Hospital · Yangzhou, Jiangsu · NCT07811687

• Coil-assisted small-diameter stent shunt reduction for refractory HE after TIPS

  A coil-assisted, small-diameter covered-stent technique is being tested to see if it can safely and effectively reduce shunt flow and lessen recurrent hepatic encephalopathy in people with a prior TIPS.

  Recruiting Air Force Military Medical University, China · Xi'an, Shaanxi · NCT07799948

• Tegoprazan to prevent GI complications in ischemic stroke patients on antiplatelet therapy

  This trial tests whether tegoprazan can lower gastrointestinal complications in adults with ischemic stroke or TIA who are starting antiplatelet therapy.

  Recruiting at 24 sites Phase 3 Hanyang University · Busan, Busan and 23 other locations · NCT07687706

• Foscenvivint in HIV/HCV co-infected adults with liver cirrhosis and hemophilia

  This study tests whether foscenvivint can help people with liver cirrhosis due to HIV/HCV co-infection who also have hemophilia.

  Recruiting at 4 sites Phase 2 Komagome Hospital · Sapporo, Hokkaido and 3 other locations · NCT07681089

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.